SciELO - Scientific Electronic Library Online

 
vol.16 issue47Musculoskeletal disorders/pain in undergraduate nursing students in a community university in southern BrazilNursing team management: factors associated with job satisfaction author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Enfermería Global

On-line version ISSN 1695-6141

Abstract

PALMES-FERRERA, Mercedes et al. Main complications associated with the administration of intraperitoneal and intravenous chemotherapy in ovarian cancer patients. Enferm. glob. [online]. 2017, vol.16, n.47, pp.175-192.  Epub July 01, 2017. ISSN 1695-6141.  http://dx.doi.org/10.6018/eglobal.16.3.260351.

Background

Ovarian cancer displays the highest death rates amongst all gynaecologic cancers. Most cases are diagnosed at an advanced stage of the disease and the treatment of choice is generally the combination therapy of intraperitoneal (IP) and intravenous (IV) chemotherapy. While this approach has been shown to prolong survival, multiple associated toxicities have been reported.

Objective

To identify the side effects and complications resulting from IP+IV chemotherapy treatment in stage III and stage IV ovarian cancer patients during the 2007-2015 period.

Methods

A descriptive, longitudinal and retrospective study was performed. A group of 17 women diagnosed with stage III and stage IV ovarian cancer were treated with IP+IV chemotherapy in Hospital Clínic de Barcelona during the period 2007-2015.

Results

Of the 17 patients who were treated with IP+IV chemotherapy, only 5 (29,41%) completed the 6 cycles of treatment. Notably, 12 (70,58%) patients discontinued the treatment due to a series of complications, which were frequently associated with IP reservoir and psychological disorders. The most commonly reported side effects were asthenia, neurotoxicity and abdominal pain.

Conclusions

The majority of patients discontinued their prescribed therapy due to complications associated with IP reservoir and psychological disorders. We believe that the nurse plays a key role, not only in managing the technical aspects of the therapy but also in providing patients with emotional support throughout their journey.

Keywords : Intraperitoneal chemotherapy; nursing care; ovarian cancer; adverse effects; complications; toxicity.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )